RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-12 5:00 pm Sale | 2023-06-08 | 13D | Satsuma Pharmaceuticals, Inc. STSA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,944,252 (Position Closed) | Filing |
| 2023-04-18 4:30 pm Purchase | 2009-02-28 | 13D | Satsuma Pharmaceuticals, Inc. STSA | RA CAPITAL MANAGEMENT L.P. | 5,944,252 17.900% | 30,000 (+0.51%) | Filing |
| 2021-03-02 4:32 pm Purchase | 2009-02-28 | 13D | Satsuma Pharmaceuticals, Inc. STSA | RA CAPITAL MANAGEMENT L.P. | 5,914,252 18.800% | 1,232,394 (+26.32%) | Filing |